参考文献/References:
[1] 喻晶, 李运雷, 刘晓翌. 非小细胞肺癌患者不同类型样本中表皮生长因子受体基因突变的差异研究[J]. 现代检验医学杂志, 2018, 33(4): 31-33. YU Jing, LI Yunlei, LIU Xiaoyi. Detection of epidermal growth factor receptor gene mutation in different sample types of 238 patients with non-small cell lung cancer [J]. Journal of Modern Laboratory Medicine, 2018, 33(4): 31-33.
[2] TAN K S. Misclassification of the actual causes of death and its impact on analysis: A case study in nonsmall cell lung cancer[J]. Lung Cancer (Amsterdam, Netherlands), 2019, 134(7): 16-24.
[3] DU Yuzhang, HOU Guofang, ZHANG Hailong, et al. Sumoylation of the m6A-RNA methyltransferase METTL3 modulates its function[J]. Nucleic Acids Research, 2018, 46(10): 5195-5208.
[4] 史维俊, 陆飞, 温贺新, 等.m6A 甲基转移酶 METTL3 在结直肠癌中的研究进展[J]. 中国现代医 生, 2020, 58(34):189-192. SHI Weijun, LU Fei, WEN Hexin, et al. Research progress of m6A methyltransferase METTL3 in colorectal cancer[J]. China Modern Doctor, 2020, 58(34):189-192.
[5] ZHU Wei, SI Yan, XU Jun, et al. Methyltransferase like 3 promotes colorectal cancer proliferation by stabilizing CCNE1 mRNA in an m6A-dependent manner[J]. Journal of Cellular and Molecular Medicine, 2020 , 24(6):3521-3533.
[6] LIU Xia, MENG Zhen, XING Yougang, et al. MiR-127 inhibits ovarian cancer migration and invasion by upregulating ITGA6 [J]. Minerva Medica, 2021, 112(2): 309-310.
[7] 舒峤, 谭菲, 黄亮桦, 等.百令胶囊对狼疮性肾炎患 者巨噬细胞功能的影响[J].中药新药与临床药理, 2019, 30(6):733-738. SHU Qiao, TAN Fei, HUANG Lianghua, et al. Effect of bailing capsules on macrophage function by regulating miR-127 expression in lupus nephritis patients[J]. Traditional Chinese Drug Research and Clinical Pharmacology, 2019, 30(6):733-738.
[8] 黄刚, 陈霏, 肇玉博, 等. 非小细胞肺癌患者血浆 miRNA-145 和miRNA-221 表达与临床特征及术后 复发的相关性研究[J]. 现代检验医学杂志, 2019, 34(4):40-44. HUANG Gang, CHEN Fei, ZHAO Yubo, et al. Study on the correlation between the expression of microRNA145 and microRNA221 in plasma and clinical characteristics and postoperative recurrence in patients with non-small cell lung cancer [J]. Journal of Modern Laboratory Medicine,2019, 34(4): 40-44.
[9] ARBOUR K C, RIELY G J. Systemic therapy for locally advanced and metastatic non-small cell lung cancer: a review[J]. JAMA : the Journal of the American Medical Association, 2019, 322(8): 764-774.
[10] LIANG Shumei, GUAN Hongwei, LIN Xiaoyan, et al. METTL3 serves an oncogenic role in human ovarian cancer cells partially via the AKT signaling pathway[J]. Oncology Letters, 2020, 19(4): 3197-3204.
[11] BI Xuehan, L? Xiao, LIU Dajiang, et al. METTL3- mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/ mTOR pathway[J]. Cancer Gene Therapy, 2021, 28(3/4): 335-349.
[12] ZHA Xu, XI Xiaoting, FAN Xinyu, et al. Overexpression of METTL3 attenuates high-glucose induced RPE cell pyroptosis by regulating miR-25-3p/PTEN/Akt signaling cascade through DGCR8[J]. Aging, 2020, 12(9): 8137-8150.
[13] SUN Yiting, LI Song, YU Wenbin, et al. N6-methyladenosine- dependent pri-miR-17-92 maturation suppresses PTEN/TMEM127 and promotes sensitivity to everolimus in gastric cancer[J]. Cell Death & Disease, 2020, 11(10): 836.
[14] ALSAADONI H, ?AYKARA B, PEN?E S, et al. The expression levels of miR-655-3p, miR127-5p, miR- 369-3p, miR-544a in gastric cancer[J].Turkish Journal of Biochemistr,2019, 44(4), 487-491.
[15] ZENG Z L, ZHU H K, HE L F, et al. Highly expressed lncRNA FOXD3-AS1 promotes non-small cell lung cancer progression via regulating miR-127-3p/mediator complex subunit 28 axis[J]. European Review for Medical and Pharmacological Sciences, 2020, 24(5): 2525-2538.
[16] ZHANG Zibin, XIONG Liulin, XUE Lulu, et al. MiR-127-3p targeting CISD1 regulates autophagy in hypoxic-ischemic cortex[J]. Cell Death & Disease, 2021, 12(3): 279.
[17] KUANG Mingjie, XING Fei, WANG Dachuan, et al. CircUSP45 inhibited osteogenesis in glucocorticoidinduced osteonecrosis of femoral head by sponging miR-127-5p through PTEN/AKT signal pathway: Experimental studies[J]. Biochemical and Biophysical Research Communications, 2019, 509(1): 255-261.